233 related articles for article (PubMed ID: 20804725)
1. Metabolic management of brain cancer.
Seyfried TN; Kiebish MA; Marsh J; Shelton LM; Huysentruyt LC; Mukherjee P
Biochim Biophys Acta; 2011 Jun; 1807(6):577-94. PubMed ID: 20804725
[TBL] [Abstract][Full Text] [Related]
2. Targeting energy metabolism in brain cancer through calorie restriction and the ketogenic diet.
Seyfried BT; Kiebish M; Marsh J; Mukherjee P
J Cancer Res Ther; 2009 Sep; 5 Suppl 1():S7-15. PubMed ID: 20009300
[TBL] [Abstract][Full Text] [Related]
3. Targeting energy metabolism in brain cancer with calorically restricted ketogenic diets.
Seyfried TN; Kiebish M; Mukherjee P; Marsh J
Epilepsia; 2008 Nov; 49 Suppl 8():114-6. PubMed ID: 19049606
[TBL] [Abstract][Full Text] [Related]
4. Metabolic therapy: a new paradigm for managing malignant brain cancer.
Seyfried TN; Flores R; Poff AM; D'Agostino DP; Mukherjee P
Cancer Lett; 2015 Jan; 356(2 Pt A):289-300. PubMed ID: 25069036
[TBL] [Abstract][Full Text] [Related]
5. Is the restricted ketogenic diet a viable alternative to the standard of care for managing malignant brain cancer?
Seyfried TN; Marsh J; Shelton LM; Huysentruyt LC; Mukherjee P
Epilepsy Res; 2012 Jul; 100(3):310-26. PubMed ID: 21885251
[TBL] [Abstract][Full Text] [Related]
6. Targeting energy metabolism in brain cancer: review and hypothesis.
Seyfried TN; Mukherjee P
Nutr Metab (Lond); 2005 Oct; 2():30. PubMed ID: 16242042
[TBL] [Abstract][Full Text] [Related]
7. Restricted calorie ketogenic diet for the treatment of glioblastoma multiforme.
Maroon J; Bost J; Amos A; Zuccoli G
J Child Neurol; 2013 Aug; 28(8):1002-8. PubMed ID: 23670248
[TBL] [Abstract][Full Text] [Related]
8. Changes in cerebral metabolism during ketogenic diet in patients with primary brain tumors:
Artzi M; Liberman G; Vaisman N; Bokstein F; Vitinshtein F; Aizenstein O; Ben Bashat D
J Neurooncol; 2017 Apr; 132(2):267-275. PubMed ID: 28074323
[TBL] [Abstract][Full Text] [Related]
9. The calorically restricted ketogenic diet, an effective alternative therapy for malignant brain cancer.
Zhou W; Mukherjee P; Kiebish MA; Markis WT; Mantis JG; Seyfried TN
Nutr Metab (Lond); 2007 Feb; 4():5. PubMed ID: 17313687
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic benefit of combining calorie-restricted ketogenic diet and glutamine targeting in late-stage experimental glioblastoma.
Mukherjee P; Augur ZM; Li M; Hill C; Greenwood B; Domin MA; Kondakci G; Narain NR; Kiebish MA; Bronson RT; Arismendi-Morillo G; Chinopoulos C; Seyfried TN
Commun Biol; 2019; 2():200. PubMed ID: 31149644
[TBL] [Abstract][Full Text] [Related]
11. A Supplemented High-Fat Low-Carbohydrate Diet for the Treatment of Glioblastoma.
Martuscello RT; Vedam-Mai V; McCarthy DJ; Schmoll ME; Jundi MA; Louviere CD; Griffith BG; Skinner CL; Suslov O; Deleyrolle LP; Reynolds BA
Clin Cancer Res; 2016 May; 22(10):2482-95. PubMed ID: 26631612
[TBL] [Abstract][Full Text] [Related]
12. Perspectives on the metabolic management of epilepsy through dietary reduction of glucose and elevation of ketone bodies.
Greene AE; Todorova MT; Seyfried TN
J Neurochem; 2003 Aug; 86(3):529-37. PubMed ID: 12859666
[TBL] [Abstract][Full Text] [Related]
13. The glucose ketone index calculator: a simple tool to monitor therapeutic efficacy for metabolic management of brain cancer.
Meidenbauer JJ; Mukherjee P; Seyfried TN
Nutr Metab (Lond); 2015; 12():12. PubMed ID: 25798181
[TBL] [Abstract][Full Text] [Related]
14. The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies.
Maalouf M; Rho JM; Mattson MP
Brain Res Rev; 2009 Mar; 59(2):293-315. PubMed ID: 18845187
[TBL] [Abstract][Full Text] [Related]
15. Mitochondria: The ketogenic diet--A metabolism-based therapy.
Vidali S; Aminzadeh S; Lambert B; Rutherford T; Sperl W; Kofler B; Feichtinger RG
Int J Biochem Cell Biol; 2015 Jun; 63():55-9. PubMed ID: 25666556
[TBL] [Abstract][Full Text] [Related]
16. Toward a cancer-specific diet.
Bozzetti F; Zupec-Kania B
Clin Nutr; 2016 Oct; 35(5):1188-95. PubMed ID: 25707910
[TBL] [Abstract][Full Text] [Related]
17. Effects of ketone bodies in Alzheimer's disease in relation to neural hypometabolism, β-amyloid toxicity, and astrocyte function.
Hertz L; Chen Y; Waagepetersen HS
J Neurochem; 2015 Jul; 134(1):7-20. PubMed ID: 25832906
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic potential of targeting glucose metabolism in glioma stem cells.
Nakano I
Expert Opin Ther Targets; 2014 Nov; 18(11):1233-6. PubMed ID: 25077882
[TBL] [Abstract][Full Text] [Related]
19. The ketogenic diet for the treatment of malignant glioma.
Woolf EC; Scheck AC
J Lipid Res; 2015 Jan; 56(1):5-10. PubMed ID: 24503133
[TBL] [Abstract][Full Text] [Related]
20. The metabolic impact of β-hydroxybutyrate on neurotransmission: Reduced glycolysis mediates changes in calcium responses and KATP channel receptor sensitivity.
Lund TM; Ploug KB; Iversen A; Jensen AA; Jansen-Olesen I
J Neurochem; 2015 Mar; 132(5):520-31. PubMed ID: 25330271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
